1. Home
  2. KULR vs AADI Comparison

KULR vs AADI Comparison

Compare KULR & AADI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KULR
  • AADI
  • Stock Information
  • Founded
  • KULR 2013
  • AADI 2011
  • Country
  • KULR United States
  • AADI United States
  • Employees
  • KULR N/A
  • AADI N/A
  • Industry
  • KULR Electrical Products
  • AADI Biotechnology: Pharmaceutical Preparations
  • Sector
  • KULR Technology
  • AADI Health Care
  • Exchange
  • KULR Nasdaq
  • AADI Nasdaq
  • Market Cap
  • KULR 55.3M
  • AADI 49.0M
  • IPO Year
  • KULR N/A
  • AADI N/A
  • Fundamental
  • Price
  • KULR $0.39
  • AADI $2.11
  • Analyst Decision
  • KULR Buy
  • AADI Hold
  • Analyst Count
  • KULR 1
  • AADI 3
  • Target Price
  • KULR $1.00
  • AADI $1.75
  • AVG Volume (30 Days)
  • KULR 5.1M
  • AADI 114.7K
  • Earning Date
  • KULR 11-13-2024
  • AADI 11-06-2024
  • Dividend Yield
  • KULR N/A
  • AADI N/A
  • EPS Growth
  • KULR N/A
  • AADI N/A
  • EPS
  • KULR N/A
  • AADI N/A
  • Revenue
  • KULR $9,700,738.00
  • AADI $25,070,000.00
  • Revenue This Year
  • KULR N/A
  • AADI $8.10
  • Revenue Next Year
  • KULR $86.04
  • AADI $8.54
  • P/E Ratio
  • KULR N/A
  • AADI N/A
  • Revenue Growth
  • KULR 4.20
  • AADI 7.80
  • 52 Week Low
  • KULR $0.10
  • AADI $1.21
  • 52 Week High
  • KULR $0.90
  • AADI $5.70
  • Technical
  • Relative Strength Index (RSI)
  • KULR 58.36
  • AADI 56.23
  • Support Level
  • KULR $0.36
  • AADI $1.98
  • Resistance Level
  • KULR $0.50
  • AADI $2.40
  • Average True Range (ATR)
  • KULR 0.04
  • AADI 0.11
  • MACD
  • KULR 0.01
  • AADI 0.01
  • Stochastic Oscillator
  • KULR 51.39
  • AADI 36.96

About KULR KULR Technology Group Inc.

KULR Technology Group Inc develops and commercializes high-performance thermal management technologies for electronics, batteries, and other components. The company is focused on targeting the following applications: electric vehicles and autonomous driving systems; artificial intelligence and Cloud computing; energy storage; and 5G communication technologies.

About AADI Aadi Bioscience Inc.

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

Share on Social Networks: